Search all trials

Find therapies in clinical trials near you – page 14

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Durvalumab and Chemo-Immunotherapy for Patients with Stage III Unresectable Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Croatia

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Osimertinib

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

InvestigationalNo placebo

Study Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Amivantamab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Durvalumab and Stereotactic Body Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

InvestigationalNo placebo

Study of Amivantamab and Cetrelimab for Patients with Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Amivantamab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study of Hydroxychloroquine Effects in Patients with Resectable Head and Neck Cancer or Non-small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Hydroxychloroquine Sulfate

Contact Research Centre

Non-small cell lung cancer+4

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Azacitidine and Pembrolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Platinum Treatment

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study of Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Osimertinib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bemcentinib

Contact Research Centre

Find therapies in clinical trials near you – page 14

327 trials match your criteria

Non-small cell lung cancer

Study of Durvalumab and Chemo-Immunotherapy for Patients with Stage III Unresectable Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

Non-small cell lung cancer+1

Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer

Non-small cell lung cancer

Study on Durvalumab and Stereotactic Body Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer

Non-small cell lung cancer+1

Study of Amivantamab and Cetrelimab for Patients with Metastatic Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Non-small cell lung cancer+1

Study of Hydroxychloroquine Effects in Patients with Resectable Head and Neck Cancer or Non-small Cell Lung Cancer

Non-small cell lung cancer+4

Study on the Safety and Effectiveness of Azacitidine and Pembrolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Platinum Treatment

Non-small cell lung cancer+1

Study of Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment

Non-small cell lung cancer

Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.